New Delhi, April 5
Drug firm Sanofi on Friday said it has obtained approval for IMOVAX-Polio, an alternative injectable vaccine, to replace the Inactivated Polio Vaccine (IPV) ShanIP in India.
IMOVAX-Polio is an alternative IPV vaccine that has been used in more than 100 countries for over 40 years, a Sanofi India spokesperson said.
The vaccine has the same composition/formulation as ShanIPV, the spokesperson added.
“We wish to assure all stakeholders that there will be no shortage of IPV vaccines in India on our account, towards safeguarding the nation's status of remaining polio-free. We remain fully committed to fulfilling our public health mission in India," the spokesperson noted. To ensure that there is no interruption to the availability of IPV vaccines, the French firm has already obtained approvals for IMOVAX-Polio.
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
Public at large thinks criminal trials are ‘neither free nor fair’, laments Supreme Court
Highlighting the poor performance of public prosecutors, a B...
Blue corner notice issued against Prajwal Revanna, says Karnataka Home Minister Parameshwara
Says the Special Investigation Team formed to probe the sex ...
Nijjar killing: Residents of accused Kamalpreet’s native village in Jalandhar say he migrated to Canada on student visa
Relatives express shock on the news of Kamalpreet's arrest, ...
CISCE to announce Classes 10, 12 results on Monday; know where to check your result
Board to discontinue compartment exams
Chhattisgarh Congress leader Radhika Khera resigns from party, cites opposition to Ram temple visit
Khera and Chhattisgarh Congress' communication wing chairper...
